Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Biotech
Vicebio hauls in $100M series B to push RSV shot through phase 1
The respiratory syncytial virus space may have filled up over the past year, but that isn’t deterring Vicebio or its investors.
James Waldron
Sep 23, 2024 3:00am
GSK surrenders HSV vaccine hopes after phase 2 fail
Sep 11, 2024 4:21am
Pfizer, Valneva show Lyme disease shot effective for 2nd booster
Sep 3, 2024 4:30am
GSK drops ph. 2 HPV vaccine over lack of best-in-class potential
Jul 31, 2024 8:06am
'Active' vaccine adjuvant boosts COVID, flu antibodies in mice
Jul 9, 2024 4:00am
Moderna flu/COVID beats immune responses for approved shots
Jun 10, 2024 6:30am